$2.95 -0.04 (-1.34%)
11/27/2009 1:00 PM

Vical, Inc. (VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Featured Broker Partners